• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评估普通医学期刊中的阿片类药物广告。

Systematic assessment of opioid advertisements in general medical journals.

机构信息

Second-year resident in obstetrics and gynecology at McMaster University in Hamilton, Ont.

Second-year resident in physical medicine and rehabilitation at the University of Toronto in Ontario.

出版信息

Can Fam Physician. 2023 Mar;69(3):192-197. doi: 10.46747/cfp.6903192.

DOI:10.46747/cfp.6903192
PMID:36944508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10030128/
Abstract

OBJECTIVE

To systematically examine the content of opioid-related advertisements.

DESIGN

Content analysis and quantitative assessment.

SETTING

North America.

PARTICIPANTS

Researchers examined advertisements in 2 issues per year from 1996 to 2016 of , the , and the .

MAIN OUTCOME MEASURES

Number of advertisements, nature of the claims made, and quality of cited evidence in the advertisements.

RESULTS

Opioid advertisements composed 89 of the 3173 pharmaceutical advertisements in 210 journal issues searched. Seventy-three advertisements were able to be obtained for analysis. Thirty-four (46.6%) did not mention the addictive potential of opioids, and 54 of 73 (74.0%) did not mention the possibility of death. All referenced studies in advertisements were funded by pharmaceutical organizations or had pharmaceutical company employees as authors. No advertisements cited high-quality evidence.

CONCLUSION

Many claims of the effectiveness and safety of opioids were published in medical journals through advertisements. Advertisements did not usually mention key negative information about opioids. Although the extent to which these advertisements directly influenced the development of the opioid crisis in North America is unknown, the marked omission of important detrimental effects of opioids may have played a role. Further efforts to restrict opioid marketing may be warranted.

摘要

目的

系统地考察阿片类药物相关广告的内容。

设计

内容分析和定量评估。

地点

北美。

参与者

研究人员对 1996 年至 2016 年期间《新英格兰医学杂志》、《柳叶刀》和《加拿大医学会杂志》每两年一期的广告进行了检查。

主要观察指标

广告数量、广告中声称的性质以及广告中引用证据的质量。

结果

在搜索的 210 期杂志中,3173 个医药广告中有 89 个是阿片类药物广告。有 73 个广告可用于分析。34 个(46.6%)广告未提及阿片类药物的成瘾潜力,54 个(74.0%)广告未提及死亡的可能性。广告中引用的所有研究均由制药组织资助,或有制药公司员工作为作者。没有广告引用高质量的证据。

结论

许多关于阿片类药物有效性和安全性的声明都是通过广告在医学期刊上发表的。广告通常没有提及阿片类药物的关键负面信息。尽管这些广告在多大程度上直接导致了北美阿片类药物危机尚不清楚,但明显遗漏了阿片类药物的重要有害影响可能起到了一定作用。进一步限制阿片类药物营销的努力可能是合理的。

相似文献

1
Systematic assessment of opioid advertisements in general medical journals.系统评估普通医学期刊中的阿片类药物广告。
Can Fam Physician. 2023 Mar;69(3):192-197. doi: 10.46747/cfp.6903192.
2
Differences in the volume of pharmaceutical advertisements between print general medical journals.印刷普通医学期刊中药物广告数量的差异。
PLoS One. 2014 Jan 8;9(1):e84790. doi: 10.1371/journal.pone.0084790. eCollection 2014.
3
Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.制药公司在医学期刊上刊登的关于其产品在2000年至2006年相对于1990年至1999年的健康经济优势的广告。
J Manag Care Pharm. 2008 Oct;14(8):749-55. doi: 10.18553/jmcp.2008.14.8.749.
4
Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.瑞士药品营销新法规下医学期刊中药品广告的准确性
BMC Med Inform Decis Mak. 2008 Dec 31;8:61. doi: 10.1186/1472-6947-8-61.
5
Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study.不同监管控制下的澳大利亚、加拿大和美国家庭医学期刊中处方药广告的质量:一项横断面研究。
BMJ Open. 2020 Jul 19;10(7):e034993. doi: 10.1136/bmjopen-2019-034993.
6
How patient outcomes are reported in drug advertisements.药物广告中如何报告患者治疗结果。
Can Fam Physician. 1999 May;45:1213-6.
7
Quality of pharmaceutical advertisements in medical journals: a systematic review.医学期刊中药品广告的质量:一项系统综述。
PLoS One. 2009 Jul 22;4(7):e6350. doi: 10.1371/journal.pone.0006350.
8
The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.药品广告中引用参考文献的可获取性及原创研究的赞助情况。
CMAJ. 2005 Feb 15;172(4):487-91. doi: 10.1503/cmaj.1031940.
9
Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.医药期刊中药品广告对 FDA 指南和安全处方内容的遵从性。
PLoS One. 2011;6(8):e23336. doi: 10.1371/journal.pone.0023336. Epub 2011 Aug 17.
10
Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.加拿大一本医学期刊中制药广告参考文献的方法学质量与相关性
CMAJ. 1994 Jul 1;151(1):47-54.

引用本文的文献

1
Pharmaceutical company responses to Canadian opioid advertising restrictions: A framing analysis.制药公司对加拿大阿片类药物广告限制的回应:框架分析。
PLoS One. 2023 Jun 29;18(6):e0287861. doi: 10.1371/journal.pone.0287861. eCollection 2023.
2
Chronic pain in family practice: research and insights.家庭医疗中的慢性疼痛:研究与见解
Can Fam Physician. 2023 Mar;69(3):153. doi: 10.46747/cfp.6903153.

本文引用的文献

1
Association of Opioid Overdose With Opioid Prescriptions to Family Members.阿片类药物过量与向家庭成员开具阿片类药物处方的关联。
JAMA Intern Med. 2019 Sep 1;179(9):1186-1192. doi: 10.1001/jamainternmed.2019.1064.
2
Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.制药行业阿片类产品营销与阿片类药物相关过量死亡率的关联。
JAMA Netw Open. 2019 Jan 4;2(1):e186007. doi: 10.1001/jamanetworkopen.2018.6007.
3
Medical Marketing in the United States, 1997-2016.美国的医疗营销,1997-2016 年。
JAMA. 2019 Jan 1;321(1):80-96. doi: 10.1001/jama.2018.19320.
4
Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.制药行业向医生推销阿片类产品与随后的阿片类药物处方之间的关联。
JAMA Intern Med. 2018 Jun 1;178(6):861-863. doi: 10.1001/jamainternmed.2018.1999.
5
Industry Payments to Physicians for Opioid Products, 2013-2015.2013 - 2015年制药行业向医生支付的阿片类产品款项
Am J Public Health. 2017 Sep;107(9):1493-1495. doi: 10.2105/AJPH.2017.303982.
6
Academic Detailing: "Marketing" the Best Evidence to Clinicians.学术推广:向临床医生“推销”最佳证据。
JAMA. 2017 Jan 24;317(4):361-362. doi: 10.1001/jama.2016.16036.
7
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.加拿大减少处方阿片类药物危害的有效政策:从过去的失败中吸取教训。
CMAJ. 2016 Dec 6;188(17-18):1240-1244. doi: 10.1503/cmaj.160356. Epub 2016 Nov 7.
8
Opioids for chronic pain: a knowledge assessment of nonpain specialty providers.用于慢性疼痛的阿片类药物:非疼痛专科医疗服务提供者的知识评估
J Pain Res. 2016 Mar 10;9:129-35. doi: 10.2147/JPR.S98273. eCollection 2016.
9
Primary Care Physicians' Knowledge and Attitudes Regarding Prescription Opioid Abuse and Diversion.初级保健医生对处方阿片类药物滥用和转移的知识与态度。
Clin J Pain. 2016 Apr;32(4):279-84. doi: 10.1097/AJP.0000000000000268.
10
Pharmaceutical overdose deaths, United States, 2010.2010年美国药物过量致死情况
JAMA. 2013 Feb 20;309(7):657-9. doi: 10.1001/jama.2013.272.